Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.45 |
| ▸ | WDR5 | P61964 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2298722 | 0.91 | CYP2C9 (0.50) | CYP2C9CYP3A4CYP2C19KCNH2WDR5 | |
| SCHEMBL2299510 | 0.91 | CYP3A4 (0.48) | CYP2C9CYP3A4CYP2C19KCNH2WDR5 | |
| SCHEMBL2298288 | 0.89 | CYP2C9 (0.46) | CYP2C9CYP3A4CYP2C19KCNH2WDR5 | |
| SCHEMBL2297865 | 0.87 | CYP2C9 (0.43) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2299493 | 0.87 | CYP2C9 (0.49) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL14697724 | 0.85 | CYP2C9 (0.51) | CYP2C9CYP3A4CYP2C19KCNH2WDR5 | |
| SCHEMBL2299481 | 0.85 | CYP2C9 (0.48) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2296829 | 0.85 | CYP2C9 (0.52) | CYP2C9CYP3A4CYP2C19KCNH2WDR5 | |
| SCHEMBL2300225 | 0.84 | CYP2C9 (0.47) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2299499 | 0.84 | CYP2C9 (0.42) | CYP2C9CYP3A4CYP2C19KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011103063-A1 | THERAPEUTIC COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2011-08-25 | — | — | WO | disclosed |